INOVIO (NASDAQ:INO), a US-based biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-associated diseases, cancers and infectious diseases, announced on Monday that its second quarter 2025 financial results will be released after the market closes on 12 August 2025.

Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.

The webcast will be archived and available for replay for 90 days after the event.